Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

Rare Cancers

The FDA approval of avapritinib marks the first time a drug has been approved specifically for patients with GIST harboring PDGFRA exon 18 mutations, which are involved in approximately 10% of GIST cases.

Results 1 - 2 of 2